Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis-Reference-Cited by-同舟云学术

Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis

Published:2013-03 Issue:2 Volume:65 Page:201-213
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Ellis Patricia,Kenyon Michelle,Dobo Krista

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference84 articles.

1. Quantitative structure–activity relationships of mutagenic and carcinogenic aromatic amines;Benigni;Chemical Reviews,2000

2. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology;Benigni;Chemical Reviews,2011

3. Hepatomas in CBA/Cb/Se mice and liver lesions in golden hamsters induced by hydrazine sulfate;Biancifiori;Journal of the National Cancer Institute,1970

4. A tiered approach to threshold of regulation;Cheeseman;Food and Chemical Toxicology,1999

5. Chemical Carcinogenesis Research Information System (CCRIS) accessed through United States National Library of Medicine ChemIDplus Advanced. Available from: .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical methods to manage potential impurities in drug substances;ANAL SCI TECHNOL;2022

2. ICH M7 – Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk;Mutagenic Impurities;2021-12-08

3. Permitted Daily Exposure Values: Application Considerations in Toxicological Risk Assessments;International Journal of Toxicology;2020-08-14

4. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses;Regulatory Toxicology and Pharmacology;2019-12

5. Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides;Regulatory Toxicology and Pharmacology;2018-04